|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02361 SINOHEALTH HLDG
Nominal 
4.500 0.000 (0.000%) | 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 396,194 | 11.082% | 356,668 | 324,166 | 202,073 | 177,750 |
| Cost of Sales | (172,722) | -12.572% | (197,560) | (131,527) | (71,867) | (71,654) |
| Gross Profit | 223,472 | 40.453% | 159,108 | 192,639 | 130,206 | 106,096 |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (24,079) | 799.141% | (2,678) | (2,855) | (691) | (1,303) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | (416) | 0 | 0 | |
| Profit / (Loss) before Taxation | 110,741 | 103.291% | 54,474 | 95,529 | 76,072 | 67,115 | |
| Taxation | (9,801) | 3655.172% | (261) | (23,551) | (10,743) | (12,736) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 1,092 | -29.320% | 1,545 | 6,835 | 2,597 | 1,710 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 102,032 | 82.991% | 55,758 | 78,813 | 67,926 | 56,089 | |
| 2023/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | (26,028) | 319.603% | (6,203) | 284 | (3,959) | (8,494) |
| Depreciation & Amortisation | 8,566 | -1.867% | 8,729 | 7,352 | 7,883 | 5,842 |
| Directors' Emoluments | 2,306 | 16.406% | 1,981 | 1,376 | 1,584 | 1,333 |
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/12 - Final | %Chg (Compare to Final) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 23.940 | 76.289% | 13.580 | 21.120 | -- | -- |
| DPS (cts) | 6.574 | -- | 3.493 | -- | -- | -- |
| Dividend Payout Ratio (%) | 27.461% | -- | 25.720% | -- | -- | -- |
| Cash flow per share ($) | 0.186 | -- | 0.079 | 0.161 | -- | -- |
| NBV per share ($) | 1.557 | -- | 1.538 | -- | -- | -- |
| Remarks: | Real time quote last updated: 25/11/2024 08:50 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 41,675,000 |
| %Change | -12.874% |
| EPS / (LPS) | RMB 0.100 |
| NBV Per Share (¥) | RMB 1.514 |